Active — Not RecruitingNot Applicable

Vagus Nerve Response in Gastroparesis Patients

United States40 participantsStarted 2019-09-01

Plain-language summary

This study aims to characterize how vagus nerve compound action potentials (CNAPs) conduct along the vagus nerve in gastroparetic patients receiving GES therapy using a flexible, non-invasive multielectrode array (MEA).

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Gastroparetic patient with a stimulator (Enterra Device placed)
✓. Aged 18-80 years
✓. Willing to have electrodes placed on the neck

Exclusion criteria

✕. Unable to provide consent
✕. Pregnant females
✕. Prisoners

What they're measuring

Optimal MEA configuration

Timeframe: 3 years

GES and symptom survey

Timeframe: 3 years

Trial details

NCT IDNCT04207996

SponsorIndiana University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-08-31

View on ClinicalTrials.gov More Gastroparesis trials